메뉴 건너뛰기




Volumn 5, Issue 3, 2007, Pages 333-335

Combating the growing problem of methicillin-resistant Staphylococcus aureus: Do the newer antibiotics represent a better alternative to vancomycin?

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DICLOXACILLIN; GENTAMICIN; LINEZOLID; METICILLIN; NEW DRUG; OXACILLIN; PENICILLIN G; TIGECYCLINE; VANCOMYCIN; ACETAMIDE DERIVATIVE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; MINOCYCLINE; OXAZOLIDINONE DERIVATIVE; QUINUPRISTIN-DALFOPRISTIN; UNCLASSIFIED DRUG; VIRGINIAMYCIN;

EID: 34447254269     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.3.333     Document Type: Editorial
Times cited : (9)

References (27)
  • 1
    • 13944274479 scopus 로고    scopus 로고
    • Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey
    • Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin. Infect. Dis. 40(4), 562-573 (2005).
    • (2005) Clin. Infect. Dis , vol.40 , Issue.4 , pp. 562-573
    • Deresinski, S.1
  • 2
    • 15944389483 scopus 로고    scopus 로고
    • Community-associated MRSA - resistance and virulence converge
    • Chambers HF. Community-associated MRSA - resistance and virulence converge. N. Engl. J. Med. 352(14), 1485-1487 (2005).
    • (2005) N. Engl. J. Med , vol.352 , Issue.14 , pp. 1485-1487
    • Chambers, H.F.1
  • 3
    • 33644923830 scopus 로고    scopus 로고
    • laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
    • Styers D, Sheehan DJ, Hogan P, Sahm DF. laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5, 2 (2006).
    • (2006) Ann. Clin. Microbiol. Antimicrob , vol.5 , pp. 2
    • Styers, D.1    Sheehan, D.J.2    Hogan, P.3    Sahm, D.F.4
  • 4
    • 33747343208 scopus 로고    scopus 로고
    • Methicillin-resistant S. aureus infections among patients in the emergency department
    • Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N. Engl. J. Med. 355(7), 666-674 (2006).
    • (2006) N. Engl. J. Med , vol.355 , Issue.7 , pp. 666-674
    • Moran, G.J.1    Krishnadasan, A.2    Gorwitz, R.J.3
  • 5
    • 33144454355 scopus 로고    scopus 로고
    • Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections
    • King MD, Humphrey BJ, Wang YF, Kourbatova EV, Ray SM, Blumberg HM. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann. Intern. Med. 144(5), 309-317 (2006).
    • (2006) Ann. Intern. Med , vol.144 , Issue.5 , pp. 309-317
    • King, M.D.1    Humphrey, B.J.2    Wang, Y.F.3    Kourbatova, E.V.4    Ray, S.M.5    Blumberg, H.M.6
  • 6
    • 4744357981 scopus 로고    scopus 로고
    • Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers
    • Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin. Infect. Dis. 39(7), 971-979 (2004).
    • (2004) Clin. Infect. Dis , vol.39 , Issue.7 , pp. 971-979
    • Ellis, M.W.1    Hospenthal, D.R.2    Dooley, D.P.3    Gray, P.J.4    Murray, C.K.5
  • 7
    • 29944440080 scopus 로고    scopus 로고
    • The management of infections due to drug-resistant Gram-positive bacteria
    • Moellering RC Jr. The management of infections due to drug-resistant Gram-positive bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 24(12), 777-779 (2005).
    • (2005) Eur. J. Clin. Microbiol. Infect. Dis , vol.24 , Issue.12 , pp. 777-779
    • Moellering Jr., R.C.1
  • 8
    • 0035746948 scopus 로고    scopus 로고
    • Limitations of presently available glycopeptides in the treatment of Gram-positive infection
    • Ziglam HM, Finch RG. Limitations of presently available glycopeptides in the treatment of Gram-positive infection. Clin. Microbiol. Infect. 7(Suppl. 4), 53-65 (2001).
    • (2001) Clin. Microbiol. Infect , vol.7 , Issue.SUPPL. 4 , pp. 53-65
    • Ziglam, H.M.1    Finch, R.G.2
  • 9
    • 0034058528 scopus 로고    scopus 로고
    • Vancomycin-resistant enterococcal infections
    • Murray BE. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342(10), 710-721 (2000).
    • (2000) N. Engl. J. Med , vol.342 , Issue.10 , pp. 710-721
    • Murray, B.E.1
  • 10
    • 29244439618 scopus 로고    scopus 로고
    • Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy
    • Sakoulas G, Moellering RC Jr, Eliopoulos GM. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin. Infect. Dis. 42(Suppl. 1), S40-S50 (2006).
    • (2006) Clin. Infect. Dis , vol.42 , Issue.SUPPL. 1
    • Sakoulas, G.1    Moellering Jr, R.C.2    Eliopoulos, G.M.3
  • 11
    • 2942515665 scopus 로고    scopus 로고
    • Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
    • Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC Jr. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin. Infect. Dis. 38(12), 1700-1705 (2004).
    • (2004) Clin. Infect. Dis , vol.38 , Issue.12 , pp. 1700-1705
    • Moise-Broder, P.A.1    Sakoulas, G.2    Eliopoulos, G.M.3    Schentag, J.J.4    Forrest, A.5    Moellering Jr., R.C.6
  • 12
    • 2942558870 scopus 로고    scopus 로고
    • Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
    • Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42(6), 2398-2402 (2004).
    • (2004) J. Clin. Microbiol , vol.42 , Issue.6 , pp. 2398-2402
    • Sakoulas, G.1    Moise-Broder, P.A.2    Schentag, J.3    Forrest, A.4    Moellering Jr, R.C.5    Eliopoulos, G.M.6
  • 13
    • 33846810101 scopus 로고    scopus 로고
    • Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections
    • Drew RH. Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections. Pharmacotherapy 27(2), 227-249 (2007).
    • (2007) Pharmacotherapy , vol.27 , Issue.2 , pp. 227-249
    • Drew, R.H.1
  • 14
    • 0037442373 scopus 로고    scopus 로고
    • Quinupristin-dalfopristin and linezolid: Evidence and opinion
    • Eliopoulos GM. Quinupristin-dalfopristin and linezolid: evidence and opinion. Clin. Infect. Dis. 36(4), 473-481 (2003).
    • (2003) Clin. Infect. Dis , vol.36 , Issue.4 , pp. 473-481
    • Eliopoulos, G.M.1
  • 16
    • 0034425844 scopus 로고    scopus 로고
    • Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections
    • Stevens DL, Smith LG, Bruss JB et al. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 44(12), 3408-3413 (2000).
    • (2000) Antimicrob. Agents Chemother , vol.44 , Issue.12 , pp. 3408-3413
    • Stevens, D.L.1    Smith, L.G.2    Bruss, J.B.3
  • 17
    • 19544369670 scopus 로고    scopus 로고
    • Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections
    • Weigelt J, Itani K, Stevens D, Lau W, Dryden M, Knirsch C. Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 49(6), 2260-2266 (2005).
    • (2005) Antimicrob. Agents Chemother , vol.49 , Issue.6 , pp. 2260-2266
    • Weigelt, J.1    Itani, K.2    Stevens, D.3    Lau, W.4    Dryden, M.5    Knirsch, C.6
  • 18
    • 0037364869 scopus 로고    scopus 로고
    • Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia
    • Wunderink RG, Cammarata SK, Oliphant TH, Kollef MH. Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. Clin. Ther. 25(3), 980-992 (2003).
    • (2003) Clin. Ther , vol.25 , Issue.3 , pp. 980-992
    • Wunderink, R.G.1    Cammarata, S.K.2    Oliphant, T.H.3    Kollef, M.H.4
  • 19
    • 0035112879 scopus 로고    scopus 로고
    • Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study
    • Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. Clin. Infect. Dis. 32(3), 402-412 (2001).
    • (2001) Clin. Infect. Dis , vol.32 , Issue.3 , pp. 402-412
    • Rubinstein, E.1    Cammarata, S.2    Oliphant, T.3    Wunderink, R.4
  • 20
    • 0242552187 scopus 로고    scopus 로고
    • Linezolid vs vancomycin: Analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia
    • Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124(5), 1789-1797 (2003).
    • (2003) Chest , vol.124 , Issue.5 , pp. 1789-1797
    • Wunderink, R.G.1    Rello, J.2    Cammarata, S.K.3    Croos-Dabrera, R.V.4    Kollef, M.H.5
  • 21
    • 0035928419 scopus 로고    scopus 로고
    • Linezolid resistance in a clinical isolate of Staphylococcus aureus
    • Tsiodras S, Gold HS, Sakoulas G et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358(9277), 207-208 (2001).
    • (2001) Lancet , vol.358 , Issue.9277 , pp. 207-208
    • Tsiodras, S.1    Gold, H.S.2    Sakoulas, G.3
  • 22
    • 23744507999 scopus 로고    scopus 로고
    • Clinical characteristics of linezolid-resistant Staphylococcus aureus infections
    • Peeters MJ, Sarria JC. Clinical characteristics of linezolid-resistant Staphylococcus aureus infections. Am. J. Med. Sci. 330(2), 102-104 (2005).
    • (2005) Am. J. Med. Sci , vol.330 , Issue.2 , pp. 102-104
    • Peeters, M.J.1    Sarria, J.C.2
  • 23
    • 23844496128 scopus 로고    scopus 로고
    • Tigecycline: A new glycylcycline for treatment of serious infections
    • Noskin GA. Tigecycline: a new glycylcycline for treatment of serious infections. Clin. Infect. Dis. 41(Suppl. 5), S303-S314 (2005).
    • (2005) Clin. Infect. Dis , vol.41 , Issue.SUPPL. 5
    • Noskin, G.A.1
  • 24
    • 23844479577 scopus 로고    scopus 로고
    • The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: Results of 2 double-blind Phase 3 comparison studies with vancomycin-aztreonam
    • Ellis-Grosse EJ, Babinchak T, Dartois N, Rose G, Loh E. The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind Phase 3 comparison studies with vancomycin-aztreonam. Clin. Infect. Dis. 41(Suppl. 5), S341-S353 (2005).
    • (2005) Clin. Infect. Dis , vol.41 , Issue.SUPPL. 5
    • Ellis-Grosse, E.J.1    Babinchak, T.2    Dartois, N.3    Rose, G.4    Loh, E.5
  • 25
    • 1842503232 scopus 로고    scopus 로고
    • Daptomycin: Another novel agent for treating infections due to drug-resistant Gram-positive pathogens
    • Carpenter CF, Chambers HF. Daptomycin: another novel agent for treating infections due to drug-resistant Gram-positive pathogens. Clin. Infect. Dis. 38(7), 994-1000 (2004).
    • (2004) Clin. Infect. Dis , vol.38 , Issue.7 , pp. 994-1000
    • Carpenter, C.F.1    Chambers, H.F.2
  • 26
    • 2942665465 scopus 로고    scopus 로고
    • The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections
    • Arbeit RD, Maki D, Tally FP, Campanaro E, Eisenstein BI. The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin. Infect. Dis. 38(12), 1673-1681 (2004).
    • (2004) Clin. Infect. Dis , vol.38 , Issue.12 , pp. 1673-1681
    • Arbeit, R.D.1    Maki, D.2    Tally, F.P.3    Campanaro, E.4    Eisenstein, B.I.5
  • 27
    • 33747365321 scopus 로고    scopus 로고
    • Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
    • Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355(7), 653-665 (2006).
    • (2006) N. Engl. J. Med , vol.355 , Issue.7 , pp. 653-665
    • Fowler Jr, V.G.1    Boucher, H.W.2    Corey, G.R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.